Ebola virus dynamics in mice treated with favipiravir - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Antiviral Research Year : 2015

Ebola virus dynamics in mice treated with favipiravir


The polymerase inhibitor favipiravir is a candidate for the treatment of Ebola virus disease. Here, we designed a mathematical model to characterize the viral dynamics in 20 mice experimentally infected with Ebola virus, which were either left untreated or treated with favipiravir at 6 or 8 days post infection. This approach provided estimates of kinetic parameters of Ebola virus reproduction, such as the half-life of productively infected cells, of about 6 hours, and the basic reproductive number which indicates that virus produced by a single infected cell productively infects about 9 new cells. Furthermore, the model predicted that favipiravir efficiently blocks viral production, reaching an antiviral effectiveness of 95% and 99.6% at 2 and 6 days after initiation of treatment, respectively. The model could be particularly helpful to guide future studies evaluating favipiravir in larger animals.
Fichier principal
Vignette du fichier
ms20150909.pdf (876.38 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-01196078 , version 1 (09-09-2015)



Vincent Madelain, Lisa Oestereich, Frederik Graw, Thi-Huyen Nguyen, Xavier de Lamballerie, et al.. Ebola virus dynamics in mice treated with favipiravir. Antiviral Research, 2015, pp.10.1016/j.antiviral.2015.08.015. ⟨10.1016/j.antiviral.2015.08.015⟩. ⟨inserm-01196078⟩
970 View
743 Download



Gmail Facebook X LinkedIn More